Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection
Open Access
- 21 March 2014
- journal article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 49 (1), 24-32
- https://doi.org/10.1016/j.jmii.2014.01.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Accelerating Next-Generation Vaccine Development for Global Disease PreventionScience, 2013
- Immunization with Leishmania Vaccine‐Alum‐BCG and Montanide ISA 720 Adjuvants Induces Low‐Grade Type 2 Cytokines and High Levels of IgG2 Subclass Antibodies in the Vervet Monkey (Chlorocebus aethiops) ModelScandinavian Journal of Immunology, 2012
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral LeishmaniasisThe Journal of Infectious Diseases, 2012
- Adjuvants for Leishmania vaccines: from models to clinical applicationFrontiers in Immunology, 2012
- Trends in vaccine adjuvantsExpert Review of Vaccines, 2011
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasisVaccine, 2010
- Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in miceMicrobes and Infection, 2008
- Immunization with a Toll-Like Receptor 7 and/or 8 Agonist Vaccine Adjuvant Increases Protective Immunity againstLeishmania majorin BALB/c MiceInfection and Immunity, 2008
- Chemotherapy of Leishmaniasis: Past, Present and FutureCurrent Medicinal Chemistry, 2007